Skip to main content

Table 1 Patients characteristics at baseline and 24 months (n = 70)

From: Cortical unlike trabecular bone loss is not associated with vascular calcification progression in CKD patients

 Baseline24 monthsp
Demography
 Age (years)57.8 ± 10.2  
 Males (%)44 (63)  
 Body mass index (kg/m2)26.4 (22.8–31.3)  
 Diabetes (%)14 (20)  
 Smoking (%)36 (51.4)  
 CKD duration (months)25.4 ± 1.3  
Laboratory
 eGFR (mL/min/1.73m2)37.3 (24.8–51.3)31.2 (20.3–51)<  0.001
 Proteinuria (g/24 h)0.19 (0–0.49)0.43 (0–1)<  0.001
 Hemoglobin (g/dL)13.3 ± 1.612.9 ± 4.4<  0.001
 Total cholesterol (mg/dL)183 (161–205)158 (131–188)<  0.001
 HDL-cholesterol (mg/dL)49 (41–57)41 (35–48)<  0.001
 LDL-cholesterol (mg/dL)104 (85–119)87 (68–106)0.001
 Triglycerides (mg/dL)129 (99–211)127 (89–177)0.20
 Bicarbonate (mmol/L)21.9 ± 3.025.5 ± 3.8<  0.001
 Phosphate (mg/dL)3.7 (3.1–4.0)3.4 (3.1–3.8)0.04
 Ionized calcium (mmol/L)1.29 ± 0.061.32 ± 0.070.003
 Alkaline Phosphatase (U/L)79 (63–93)70.5 (60.8–94)0.17
 Intact PTH (pg/mL)88 (61–153)98 (56.5–171)0.63
Tomography
 Trabecular Bone Density (HU)202.9 ± 50.5202.5 ± 510.91
 Cortical Bone Density (HU)400 ± 89.9404 ± 94.80.40
 Coronary calcium score (AU)5.5 (0–283.8)7.5 (0–385.3)<  0.001
  1. eGFR Estimated glomerular filtration rate